Coral Laboratories Ltd

Coral Laboratories Ltd | Sector: Pharmaceuticals | ISIN: INE683E01017

Trade

Corporate Actions

07 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2023

12:00 AM

Results

View Details

04 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Nov , 2022

12:00 AM

Results

View Details

12 Aug , 2022

12:00 AM

AGM

Announcement date: 12 Aug , 2022

View Details

19 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Aug , 2022

12:00 AM

Results

View Details

08 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Aug , 2022

12:00 AM

BookCloser

View Details

Coral Laboratories Ltd News and Update

Adani Power sells Support Properties Private Ltd to AdaniConnex

24 March, 2023 |
4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Power Grid Corporation acquires Khavda II-C Transmission Ltd

23 March, 2023 |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
23 March, 2023 |
4:02 PM

Govt to sell up to 3.5% stake in HAL

IIFL News Service |
23 March, 2023 |
4:02 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	972.80	89.99	2,33,407.31	486.73	1.03	4,549.90	108.48
Divis Laboratories Ltd	2,809.00	31.40	74,497.12	310.90	1.07	1,689.83	454.85
Dr Reddys Laboratories Ltd	4,462.75	31.49	74,309.82	324.60	0.67	3,879.60	1,156.21
Cipla Ltd	877.00	25.58	70,787.11	678.52	0.57	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,517.75	48.99	51,379.40	229.00	1.58	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Coral Laboratories Ltd

Sheela R Kamdar
Independent Director

Girish Dhameja
Whole-time Director

Sushma Shashi Kadkade
Director & CFO

Saurabh Shah
Independent Director

Ruchi Anjaria
Company Sec. & Compli. Officer

Malay Doshi
Independent Director

Rajendrasinh Rana
Director

Summary

Summary Info Not Found

Reports by Coral Laboratories Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Coral Laboratories Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Coral Laboratories Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 26 March , 2023 | 02:03 PM

Knowledge Center

Coral Laboratories Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Coral Laboratories Ltd

Sheela R Kamdar

Girish Dhameja

Sushma Shashi Kadkade

Saurabh Shah

Ruchi Anjaria

Malay Doshi

Rajendrasinh Rana

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
26 March , 2023 | 02:03 PM